Advanced search
Start date

The effect of RECK or RECK B overexpression in Human Papillomavirus associated cell transformation

Grant number: 20/15732-0
Support Opportunities:Scholarships in Brazil - Post-Doctoral
Effective date (Start): September 01, 2021
Field of knowledge:Biological Sciences - Microbiology - Biology and Physiology of Microorganisms
Principal Investigator:Enrique Mario Boccardo Pierulivo
Grantee:Suellen da Silva Gomes Herbster
Host Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil
Associated scholarship(s):23/14109-6 - The effect of human papillomavirus oncoproteins expression on RECK gene regulation, BE.EP.PD


Human Papillomavirus (HPV)-induced carcinogenesis comprises alterations in Extracellular Matrix (ECM) components such as Matrix Metalloproteinases (MMP) and their regulators. REversion-inducing Cysteine-rich protein with Kazal motifs (RECK) inhibits the activation of specific MMP and its expression is frequently lost in human cancers. Different mRNA products of RECK gene may be generated by alternative splicing, including RECK B isoform (NM_001316346.2). We have previously reported that RECK overexpression (RECK+) reduced the tumorigenic potential of HPV-transformed cells both in vitro and in vivo. Additionally, we demonstrated that RECK down regulation is a consistent and clinically relevant event in the natural history of Cervical Cancer. Furthermore, RECK+ tumors displayed alterations in intratumoral inflammatory infiltrating cell populations. Here, we aim to evaluate the effect of RECK or RECK B overexpression (RECKB+) in the context of in vivo tumorigenesis, in an immunocompetent murine model and we will explore the content of extracellular vesicles of RECK+ or RECKB+ tumor cells. In a pilot study, we showed that HPV16 E6 and E7 expression was associated with reduced activation of RECK gene promoter. In the second half of the project, as part of an international collaboration with the Infections and Cancer Biology Group led by Dr. Massimo Tommasino, the candidate will carry out chromatin immunoprecipitation assays, complementary gene reporter assays and analysis of RECK and RECK B mRNA expression and stability in HPV16 E6 and/or E7 expressing cells. The data generated in this study will provide further robust evidence on the full potential of RECK as a therapeutic target in Cervical Cancer. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.